
Understanding Pasithea Therapeutics Corp (NASDAQ: KTTA)’s Growth Potential
Pasithea Therapeutics Corp (NASDAQ:KTTA) shares, rose in value on Friday, May 30, with the stock price up by 3.19% to the previous day’s close as strong demand from buyers drove the stock to $0.97. Actively observing the price movement in the last trading, the stock